Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Literacy | 8 | 2020 | 39 | 2.940 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 8 | 2017 | 65 | 2.040 |
Why?
|
| Patient Education as Topic | 6 | 2018 | 213 | 1.310 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2020 | 53 | 1.210 |
Why?
|
| Telemedicine | 2 | 2022 | 187 | 1.190 |
Why?
|
| Community Pharmacy Services | 3 | 2022 | 3 | 1.010 |
Why?
|
| Osteoporosis | 3 | 2020 | 78 | 0.970 |
Why?
|
| Radiosurgery | 8 | 2016 | 8 | 0.910 |
Why?
|
| Patient Participation | 2 | 2016 | 134 | 0.900 |
Why?
|
| Drug Labeling | 4 | 2013 | 14 | 0.890 |
Why?
|
| Self Report | 2 | 2024 | 253 | 0.850 |
Why?
|
| Referral and Consultation | 1 | 2024 | 169 | 0.850 |
Why?
|
| Depression | 3 | 2023 | 506 | 0.840 |
Why?
|
| Humans | 41 | 2024 | 17822 | 0.820 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 1335 | 0.820 |
Why?
|
| Aged | 22 | 2024 | 6173 | 0.730 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 26 | 0.720 |
Why?
|
| Office Visits | 1 | 2021 | 80 | 0.700 |
Why?
|
| Pharmaceutical Services | 2 | 2018 | 34 | 0.680 |
Why?
|
| Comprehension | 2 | 2017 | 17 | 0.680 |
Why?
|
| Fractures, Bone | 1 | 2020 | 95 | 0.660 |
Why?
|
| Communication | 4 | 2017 | 194 | 0.660 |
Why?
|
| Mass Screening | 2 | 2016 | 678 | 0.640 |
Why?
|
| Managed Care Programs | 1 | 2021 | 325 | 0.630 |
Why?
|
| Pharmacy | 3 | 2019 | 12 | 0.630 |
Why?
|
| Female | 26 | 2024 | 12780 | 0.570 |
Why?
|
| Consumer Health Information | 1 | 2017 | 14 | 0.570 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 417 | 0.550 |
Why?
|
| Internet | 2 | 2017 | 231 | 0.520 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 332 | 0.520 |
Why?
|
| Pharmacists | 4 | 2012 | 50 | 0.520 |
Why?
|
| Middle Aged | 20 | 2024 | 8020 | 0.520 |
Why?
|
| Male | 22 | 2024 | 10145 | 0.510 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 156 | 0.480 |
Why?
|
| Professional-Patient Relations | 2 | 2012 | 47 | 0.480 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 189 | 0.470 |
Why?
|
| Awareness | 1 | 2014 | 17 | 0.460 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2014 | 93 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 382 | 0.430 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 92 | 0.410 |
Why?
|
| Adult | 15 | 2024 | 7708 | 0.410 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2011 | 3 | 0.390 |
Why?
|
| Alabama | 6 | 2016 | 23 | 0.380 |
Why?
|
| Reading | 2 | 2012 | 6 | 0.380 |
Why?
|
| Residence Characteristics | 1 | 2013 | 251 | 0.360 |
Why?
|
| Meningioma | 3 | 2018 | 4 | 0.350 |
Why?
|
| Tissue Expansion Devices | 1 | 2009 | 1 | 0.340 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 1 | 0.340 |
Why?
|
| Mammaplasty | 1 | 2009 | 2 | 0.340 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 7 | 0.340 |
Why?
|
| Mental Disorders | 3 | 2024 | 280 | 0.300 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 1931 | 0.290 |
Why?
|
| Particle Accelerators | 1 | 2007 | 1 | 0.280 |
Why?
|
| Brain Diseases | 1 | 2007 | 2 | 0.280 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 40 | 0.280 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 1219 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2007 | 70 | 0.270 |
Why?
|
| Prescription Drugs | 3 | 2016 | 31 | 0.270 |
Why?
|
| Medication Adherence | 2 | 2020 | 246 | 0.260 |
Why?
|
| Health Education | 1 | 2007 | 111 | 0.260 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 88 | 0.260 |
Why?
|
| Treatment Outcome | 6 | 2018 | 1265 | 0.240 |
Why?
|
| Mobile Applications | 1 | 2024 | 19 | 0.230 |
Why?
|
| Trigeminal Neuralgia | 3 | 2011 | 3 | 0.230 |
Why?
|
| Young Adult | 6 | 2018 | 2464 | 0.230 |
Why?
|
| Health Personnel | 1 | 2024 | 126 | 0.210 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 1323 | 0.210 |
Why?
|
| Adolescent | 6 | 2018 | 3690 | 0.200 |
Why?
|
| Demography | 2 | 2016 | 101 | 0.200 |
Why?
|
| Mental Health | 1 | 2023 | 166 | 0.190 |
Why?
|
| Educational Status | 3 | 2020 | 200 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2019 | 86 | 0.190 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2018 | 18 | 0.190 |
Why?
|
| Risk Factors | 4 | 2020 | 3362 | 0.190 |
Why?
|
| Writing | 2 | 2019 | 11 | 0.190 |
Why?
|
| Mid-Atlantic Region | 1 | 2021 | 9 | 0.180 |
Why?
|
| Neuronavigation | 3 | 2011 | 3 | 0.180 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 25 | 0.180 |
Why?
|
| Trust | 1 | 2020 | 31 | 0.180 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 5 | 0.170 |
Why?
|
| Pharmacies | 2 | 2010 | 10 | 0.170 |
Why?
|
| Pandemics | 1 | 2022 | 287 | 0.170 |
Why?
|
| Risk | 3 | 2016 | 518 | 0.170 |
Why?
|
| Peer Review | 1 | 2019 | 4 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2020 | 41 | 0.160 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1 | 0.160 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 14 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2024 | 537 | 0.150 |
Why?
|
| Internationality | 1 | 2018 | 14 | 0.150 |
Why?
|
| Calcium | 1 | 2018 | 35 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 4 | 0.150 |
Why?
|
| Retrospective Studies | 7 | 2018 | 2467 | 0.150 |
Why?
|
| Bone Density | 1 | 2018 | 97 | 0.140 |
Why?
|
| Time Factors | 4 | 2018 | 1097 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2016 | 107 | 0.140 |
Why?
|
| Age Factors | 2 | 2010 | 923 | 0.140 |
Why?
|
| Vitamin D | 1 | 2018 | 76 | 0.140 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 10 | 0.130 |
Why?
|
| Health Information Exchange | 1 | 2016 | 3 | 0.130 |
Why?
|
| Contraindications | 1 | 2016 | 14 | 0.130 |
Why?
|
| Workflow | 1 | 2016 | 11 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2018 | 146 | 0.130 |
Why?
|
| Cultural Competency | 1 | 2016 | 12 | 0.130 |
Why?
|
| Video Recording | 1 | 2016 | 12 | 0.130 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2016 | 1 | 0.130 |
Why?
|
| Stents | 2 | 2013 | 11 | 0.130 |
Why?
|
| Social Class | 1 | 2016 | 121 | 0.130 |
Why?
|
| Health Communication | 2 | 2012 | 16 | 0.130 |
Why?
|
| Logistic Models | 3 | 2020 | 928 | 0.120 |
Why?
|
| Health Care Surveys | 1 | 2016 | 230 | 0.120 |
Why?
|
| Poisoning | 1 | 2015 | 5 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2016 | 1103 | 0.120 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2015 | 25 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 77 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 630 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 2 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 321 | 0.110 |
Why?
|
| Linear Models | 2 | 2015 | 232 | 0.110 |
Why?
|
| Health Policy | 1 | 2015 | 123 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2015 | 102 | 0.110 |
Why?
|
| Medicaid | 1 | 2015 | 190 | 0.110 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2013 | 1 | 0.110 |
Why?
|
| Urolithiasis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Ureteral Obstruction | 1 | 2013 | 2 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 147 | 0.100 |
Why?
|
| Ethnic Groups | 1 | 2016 | 485 | 0.100 |
Why?
|
| Psychotherapy | 1 | 2013 | 59 | 0.100 |
Why?
|
| Sepsis | 1 | 2013 | 70 | 0.100 |
Why?
|
| Health Surveys | 1 | 2013 | 261 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2012 | 223 | 0.100 |
Why?
|
| Algorithms | 1 | 2012 | 239 | 0.090 |
Why?
|
| Data Collection | 2 | 2012 | 257 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2016 | 770 | 0.090 |
Why?
|
| Prescriptions | 1 | 2010 | 27 | 0.090 |
Why?
|
| Device Removal | 1 | 2009 | 1 | 0.090 |
Why?
|
| Wound Healing | 1 | 2009 | 5 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2009 | 1 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2009 | 1 | 0.080 |
Why?
|
| Equipment Design | 2 | 2007 | 8 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 15 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2009 | 7 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 13 | 0.080 |
Why?
|
| Medical Errors | 1 | 2009 | 17 | 0.080 |
Why?
|
| Mastectomy | 1 | 2009 | 36 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2009 | 20 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 79 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2009 | 159 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2010 | 305 | 0.080 |
Why?
|
| Counseling | 1 | 2010 | 189 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 106 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 569 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2016 | 2590 | 0.070 |
Why?
|
| Forecasting | 1 | 2007 | 75 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2007 | 300 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 381 | 0.060 |
Why?
|
| Incidence | 1 | 2009 | 1269 | 0.060 |
Why?
|
| Prevalence | 1 | 2007 | 888 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 720 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 169 | 0.050 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 6 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 91 | 0.050 |
Why?
|
| Anxiety | 1 | 2023 | 151 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 957 | 0.050 |
Why?
|
| United States | 3 | 2015 | 4007 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 329 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 107 | 0.040 |
Why?
|
| Authorship | 1 | 2019 | 5 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2018 | 51 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 260 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2018 | 256 | 0.040 |
Why?
|
| Rupture | 1 | 2016 | 2 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 2 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2016 | 2 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 6 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Oklahoma | 1 | 2015 | 2 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2015 | 9 | 0.030 |
Why?
|
| Epilepsy | 1 | 2015 | 13 | 0.030 |
Why?
|
| Poison Control Centers | 1 | 2015 | 3 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2014 | 5 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 19 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2014 | 17 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 34 | 0.030 |
Why?
|
| Ureter | 1 | 2013 | 2 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 315 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 267 | 0.030 |
Why?
|
| Patients | 1 | 2012 | 34 | 0.030 |
Why?
|
| Suicide | 1 | 2013 | 124 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2011 | 12 | 0.020 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 1 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 12 | 0.020 |
Why?
|
| Nonprescription Drugs | 1 | 2009 | 6 | 0.020 |
Why?
|
| Arthritis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2009 | 62 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 138 | 0.020 |
Why?
|
| Pain | 1 | 2009 | 79 | 0.020 |
Why?
|
| Brain Edema | 1 | 2008 | 1 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 102 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2009 | 529 | 0.020 |
Why?
|
| Child | 1 | 2013 | 2497 | 0.020 |
Why?
|
| African Americans | 1 | 2009 | 472 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 609 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2004 | 1 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 10 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 211 | 0.010 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->